ADD/ADHD News

Racial and ethnic disparities in attention-deficit/hyperactivity disorder medication persisted because of fewer diagnoses and treatments in African-American and Latino children as opposed to overdiagnoses and treatments in white children, according to study findings.

The upcoming U.S. Psychiatric and Mental Health Congress Conference will fulfill this year’s theme of “mental wellness” through a plethora of offerings, including educational sessions, networking events, poster presentations, exhibitions and more

Children exposed to acetaminophen through maternal consumption during pregnancy were at an increased risk for developing difficult behavioral symptoms, according to recently published data.

Avoiding an unhealthy diet while pregnant may reduce the risk for ADHD symptoms in early-onset persistent youth, due to lower DNA methylation of the insulin-like growth factor 2 gene in the offspring, according to data published in the Journal of Child Psychology and Psychiatry.

Adolescents with bipolar disorder, particularly those with comorbid conduct disorder, were significantly more likely to smoke cigarettes and have substance use disorder, compared with peers without mood disorders.

Pharmacological treatment for attention-deficit/hyperactivity disorder significantly reduced the probability of adolescents contracting STDs, abusing drugs and alcohol, and becoming injured, according to recent research.

College students who misused prescription stimulants were more likely to have attention-deficit/hyperactivity disorder, conduct disorder, substance use disorder and overall dysfunction, according to recent findings.

The American Academy of Pediatrics’ Committee on Pediatric Emergency Medicine and the American College of Emergency Physicians’ Pediatric Emergency Medicine Committee recently released a two-part clinical report to address knowledge gaps regarding pediatric mental health emergencies.

Study findings in Pediatrics showed a web-portal intervention for pediatricians who prescribed medications for children with attention-deficit/hyperactivity disorder improved patients’ quality of care and may lead to greater reductions in parent ratings of their children’s symptoms.

A combination of d-methylphenidate and guanfacine was more effective for attention-deficit/hyperactivity disorder than either treatment alone, according to recent findings.